ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Puerto Rico » Geriatric Medicine

Top Geriatric Medicine Prescribers in Puerto Rico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANTOLIN PADILLA MD

Geriatric Medicine

20,451

$826K

557
499 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $35

LUIS GUZMAN-LUGO M.D.

Geriatric Medicine

19,896

$559K

574
436 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$28
Average prescription price

Avg: $35

MIGUEL VELAZQUEZ VALLE M.D.

Geriatric Medicine

14,629

$411K

403
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$28
Average prescription price

Avg: $35

ARIEL CRUZ IGARTUA MD

Geriatric Medicine

13,333

$486K

596
488 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$36
Average prescription price

Avg: $35

JUAN ORTIZ GUEVARA M.D.

Geriatric Medicine

12,887

$391K

550
333 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$30
Average prescription price

Avg: $35

JOSE MUNIZ M.D.

Geriatric Medicine

12,710

$590K

406
292 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $35

NELSON DE JESUS RAMOS M.D.

Geriatric Medicine

10,414

$347K

344
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $35

LUIS DIAZ M.D.

Geriatric Medicine

9,125

$301K

305
223 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $35

PABLO DEL VALLE M.D.

Geriatric Medicine

8,842

$233K

310
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$26
Average prescription price

Avg: $35

LUZ ACEVEDO-VARGAS MD

Geriatric Medicine

7,009

$213K

281
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$30
Average prescription price

Avg: $35

ALEJANDRO MEDINA M.D.

Geriatric Medicine

6,924

$165K

475
386 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$24
Average prescription price

Avg: $35

ANTONIO SOTOMAYOR-SIERRA M.D.

Geriatric Medicine

6,571

$225K

196
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$34
Average prescription price

Avg: $35

ISMAEL TORO GRAJALES MD, MPH

Geriatric Medicine

6,560

$125K

226
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 23%

$19
Average prescription price

Avg: $35

JOSE LOPEZ M.D.

Geriatric Medicine

6,280

$205K

245
190 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $35

CARMEN MARRERO MD

Geriatric Medicine

5,309

$274K

300
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $35

JAIME RODRIGUEZ-ARIAS M.D.

Geriatric Medicine

5,303

$207K

330
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $35

HELEN ROSA SANTIAGO M.D.

Geriatric Medicine

5,295

$245K

336
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $35

SISSI BARRETO MD

Geriatric Medicine

5,070

$157K

220
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$31
Average prescription price

Avg: $35

DRA CARMEN M MARRERO PSC

Geriatric Medicine

4,095

$222K

220
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $35

GILBERTO RAMIREZ M.D.

Geriatric Medicine

3,510

$201K

276
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $35

AGUSTIN LOPEZ-MARRERO

Geriatric Medicine

3,459

$121K

136
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $35

ISMENIO MILLAN-APONTE MD

Geriatric Medicine

3,035

$85.4K

159
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$28
Average prescription price

Avg: $35

JOAN PIJEM BERRIOS M.D.

Geriatric Medicine

2,333

$126K

125
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $35

CARIDAD VARGAS

Geriatric Medicine

1,759

$56.3K

57
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$32
Average prescription price

Avg: $35

MAYRA SOTO-GOITIA M.D.

Geriatric Medicine

1,672

$56.4K

90
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$34
Average prescription price

Avg: $35

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank